CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
ERCC1 Expression-Based Randomized Phase II Study of Gemcitabine/Cisplatin Versus Irinotecan/Cisplatin in Patients with Advanced Non-small Cell Lung Cancer
Ji-Youn Han, Geon Kook Lee, Kun Young Lim, Young Ju Lee, Byung Ho Nam, Jin Soo Lee
Cancer Research and Treatment. 2017;49(3):678-687.   Published online 2016 October 11    DOI: https://doi.org/10.4143/crt.2016.365

Excel Download

ERCC1 Expression-Based Randomized Phase II Study of Gemcitabine/Cisplatin Versus Irinotecan/Cisplatin in Patients with Advanced Non-small Cell Lung Cancer
Cancer Research and Treatment. 2017;49(3):678-687   Crossref logo
Link1 Link2

Gemcitabine and cisplatin versus vinorelbine and cisplatin versus ifosfamide+gemcitabine followed by vinorelbine and cisplatin versus vinorelbine and cisplatin followed by ifosfamide and gemcitabine in stage IIIB–IV non small cell lung carcinoma: a prospective randomized phase III trial of the Gruppo Oncologico Italia Meridionale
Lung Cancer. 2003;39(2):179-189   Crossref logo
Link1 Link2

Randomized study of NavelbineR and cisplatin versus vindesine and cisplatin versus NavelbineR alone in 612 patients with advanced non-small cell lung cancer (NSCLC)
Lung Cancer. 1996;16(1):120   Crossref logo
Link1 Link2

Irinotecan/Cisplatin versus Vindesine/Cisplatin versus Irinotecan Alone in Advanced Non–Small-Cell Lung Cancer
Clinical Lung Cancer. 2001;2(3):180-181   Crossref logo
Link1 Link2

Randomized phase III trial compared cisplatin and irinotecan (CPT-P) versus cisplatin and vindesine (VDS-P) versus irinotecan alone (CPT) in patients with advanced non-small cell lung cancer (NSCLC) — The final report
Lung Cancer. 2000;29(1):28   Crossref logo
Link1 Link2

Phase I study of gemcitabine (GEM) and cisplatin (CP) for advanced non-small cell lung cancer (NSCLC)
Lung Cancer. 1994;11:116   Crossref logo
Link1 Link2

Phase II and Phase III Trials: Docetaxel/Irinotecan versus Docetaxel/Cisplatin in Advanced Non–Small-Cell Lung Cancer (WJTOG 9803)
Clinical Lung Cancer. 2001;2(3):178-179   Crossref logo
Link1 Link2

Phase II randomized trial comparing high-dose cisplatin with moderate- dose cisplatin and carboplatin in patients with advanced non-small-cell lung cancer
Lung Cancer. 1994;11(3-4):340   Crossref logo
Link1 Link2

A randomized study of cisplatin versus cisplatin plus vindesine for non-small cell lung carcinoma
Lung Cancer. 1992;8(2):138   Crossref logo
Link1 Link2

P-480 A comparative study of combination chemotherapy with docetaxell cisplatin versus gemcitabine/cisplatin for locally advanced non-small cell lung cancer
Lung Cancer. 2005;49:S242-S243   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.